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   Ten patients with advanced bladder cancer were treated with intra-arterial infusion 
therapy. The patients consisted of nine males and one female between 55 and 82 years old 
(median: 70 years). In all patients, cisplatinum (CDDP) (2 mg/kg), aclacinomycin (ACR) 
(0.5 mg/kg) and Angiotensin II (25 mg) were infused via the internal iliac artery for a 
period of about 30 minutes. Seven patients also received X-ray therapy with a linac. 
   The efficacy of this therapy was assessed by computed tomographic scanning, sonography 
and cystoscopy. As a result of this assessment, 2 patients were rated complete response 
"(CR)" , 6 partial response (PR) (showing 50% or more reduction in the lesion) and 2 no 
change "(NC)" To compare the efficacy of this therapy for two histopathologically defined 
groups of patients (patients with grades 2 and 3 cancer), one patient was rated "CR" , four "PR" and two "NC" in the grade 3 group (total 7 patients), while one was rated "CR" 
and two "PR" , in the grade 2 group (total 3 patients). In effective cases, pollakiuria and 
miction pain disappeared shortly following intra-arterial infusion therapy. As for side effects 
of the therapy, mild nausea or vomiting was observed in all patients, while leukopenia was 
noted in one patient.
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法がより有用な投与法であ るこ とは 明白な事実であ
る.今回,わ れわれは より高濃度のCDDPを 局所
に投与す る 目的で,ア ンギオテンシンH(以下AT-
IIと略す)を併用 し,満足すぺ き結果が得られたの
で,そ の詳細を報告する.
対 象 症 例
対象症例は玉985年1月以後,香川県立中央病院泌尿
器科に入院した膀胱癌患者で,男性9例,女 性1例 の

























2月に再発.同 時に多発性骨転移 も認めた.自 覚症状

























































































Fig.1.症例3の 経 過 表.
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Fig.2.動注 施行 前 後 の 骨 盤部CT.




















症例7はTCC,G3で 再発 を繰 り返し,今回は,
















40%に認 めた ものの,嘔 吐は24時間以内にほぼ消失
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3,000/mm3以下 の 白血球 減 少 症 は,1例 に 認 め た




















はるかに しの ぐもので ある との印象を受けた.し か
も,副作用が軽微で,高 齢者や全身状態の不良な症例









の 内腸骨動 脈に最 大100mgのCDDPと30mg
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